Hengliang Shi (Ru-Tong Yu, Rutong Yu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Top Venues

Journal of cellular and molecular medicine

Advanced materials (Deerfield Beach, Fla.)

Cancer immunology research

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Wang, Long Zhang, Yi Zhou, Yan Wang, Xiang Wang, Yining Zhang, Ankang Quan, Yufei Mao, Yu Zhang, Ji Qi, Zhongyu Ren, Linbo Gu, Hengliang Shi, Xiu-Ping Zhou
Chronic stress exacerbates the immunosuppressive microenvironment and progression of gliomas by reducing secretion of CCL3. Cancer immunology research (2024)
Yongkang Zhang, Hongwei Ma, Linsen Li, Chen Sun, Changshui Yu, Lansheng Wang, Duo Xu, Xu Song, Hengliang Shi
Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy. Advanced materials (Deerfield Beach, Fla.) (2024)
Yongkang Zhang, Hongwei Ma, Linsen Li, Chen Sun, Changshui Yu, Lansheng Wang, Duo Xu, Xu Song, Hengliang Shi
Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy. Advanced materials (Deerfield Beach, Fla.) 36 (29) (2024)
Xu Wang, Long Zhang, Yi Zhou, Yan Wang, Xiang Wang, Yining Zhang, Ankang Quan, Yufei Mao, Yu Zhang, Ji Qi, Zhongyu Ren, Linbo Gu, Hengliang Shi, Xiu-Ping Zhou
Chronic Stress Exacerbates the Immunosuppressive Microenvironment and Progression of Gliomas by Reducing Secretion of CCL3. Cancer immunology research 12 (5) (2024)
Xu Wang, Long Zhang, Yi Zhou, Yan Wang, Xiang Wang, Yining Zhang, Ankang Quan, Yufei Mao, Yu Zhang, Ji Qi, Zhongyu Ren, Linbo Gu, Hengliang Shi, Xiu-Ping Zhou
Chronic Stress Exacerbates the Immunosuppressive Microenvironment and Progression of Gliomas by Reducing Secretion of CCL3. Cancer immunology research 12 (5) (2024)
Yongkang Zhang, Hongwei Ma, Linsen Li, Chen Sun, Changshui Yu, Lansheng Wang, Duo Xu, Xu Song, Hengliang Shi
Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy. Advanced materials (Deerfield Beach, Fla.) (2024)
Zixuan Zhou, Bingxin Zhu, Qingming Meng, Tong Zhang, Yihao Wu, Hengliang Shi, Shangfeng Gao
Research progress in molecular pathology markers in medulloblastoma. Exploration of targeted anti-tumor therapy 4 (1) (2023)
Zixuan Zhou, Bingxin Zhu, Qingming Meng, Tong Zhang, Yihao Wu, Hengliang Shi, Shangfeng Gao
Research progress in molecular pathology markers in medulloblastoma. Exploration of targeted anti-tumor therapy 4 (1) (2023)
Xu Zhang, Runqiu Wu, Cong Tian, Wanzhou Wang, Lingni Zhou, Tongxuan Guo, Jiefeng Yu, Changyong Wu, Yang Shen, Xuejiao Liu, Hengliang Shi
GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma. Cell death discovery 8 (1) (2022)
Yu Zhang, Yan Wang, Ding Zhou, Kai Wang, Xu Wang, Xiang Wang, Yang Jiang, Min Zhao, Hengliang Shi, Xiu-Ping Zhou
Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair. Oncogene 40 (27) (2021)
Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang, Hengliang Shi
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas. Cancer biology & medicine 18 (1) (2021)
Xuejiao Liu, Chenglong Yue, Lin Shi, Guanzheng Liu, Qiyu Cao, Qianqian Shan, Yifeng Wang, Xiangyu Chen, Huan Li, Jie Wang, Shangfeng Gao, Mingshan Niu, Hengliang Shi
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. Journal of cellular and molecular medicine 24 (13) (2020)
Haoyue Xu, Yuhan Han, Gang Zhao, Long Zhang, Zongren Zhao, Zhen Wang, Liang Zhao, Lei Hua, Konduru Naveena, Jun Lu, Hengliang Shi, Hong-Mei Liu
Hypoxia-Responsive Lipid-Polymer Nanoparticle-Combined Imaging-Guided Surgery and Multitherapy Strategies for Glioma. ACS applied materials & interfaces 12 (47) (2020)
Yunnong Song, Cheng Li, Lei Jin, Jingsong Xing, Zhuang Sha, Tong Zhang, Daofei Ji, Hengliang Shi, Shangfeng Gao
RIOK2 is negatively regulated by miR-4744 and promotes glioma cell migration/invasion through epithelial-mesenchymal transition. Journal of cellular and molecular medicine 24 (8) (2020)
Hong-Lin Mao, Feng Qian, Shun Li, Jia-Wei Shen, Cheng-Kun Ye, Lei Hua, Long-Zhen Zhang, Dong-Mei Wu, Jun Lu, Hengliang Shi, Hong-Mei Liu
Delivery of Doxorubicin from Hyaluronic Acid-Modified Glutathione-Responsive Ferrocene Micelles for Combination Cancer Therapy. Molecular pharmaceutics 16 (3) (2019)
Lei Hua, Guanghui Wang, Zhen Wang, Jiale Fu, Zhen Fang, Ting Zhuang, Liang Zhao, Zhenkun Zong, Chengkun Ye, Hongmei Liu, Yufu Zhu, Hengliang Shi
Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth. Journal of neuro-oncology 143 (1) (2019)
Xiang-Long Tang, Feng Jing, Ben-Lan Lin, Sheng Cui, Hengliang Shi, Xiao-Dong Shen, Ting-Wei Wang
pH-Responsive Magnetic Mesoporous Silica-Based Nanoplatform for Synergistic Photodynamic Therapy/Chemotherapy. ACS applied materials & interfaces 10 (17) (2018)
Manyi Xie, Zhe Ji, Yaxing Bao, Yufu Zhu, Yang Xu, Lei Wang, Shangfeng Gao, Zhiyi Liu, Zilu Tian, Qingming Meng, Hengliang Shi, Rutong Yu
PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway. Journal of cellular and molecular medicine 22 (7) (2018)
Honglin Mao, Yandong Xie, Haichen Ju, Hongsen Mao, Liang Zhao, Zhen Wang, Lei Hua, Chunming Zhao, Yuling Li, Hengliang Shi, Hong-Mei Liu
Design of Tumor Microenvironment-Responsive Drug-Drug Micelle for Cancer Radiochemotherapy. ACS applied materials & interfaces 10 (40) (2018)
Yufu Zhu, Xiang Zhang, Lei Wang, Zhe Ji, Manyi Xie, Xinyu Zhou, Zhiyi Liu, Hengliang Shi, Hengliang Shi
Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling. Journal of cellular and molecular medicine 21 (11) (2017)